DT&CRO CO., Ltd. (KOSDAQ: 383930)

Market Cap	77.15B
Revenue	n/a
Net Income	n/a
Shares Out	12.73M
EPS	n/a
PE Ratio	n/a
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	25,445
Open	6,070.00
Previous Close	6,060.00
Day's Range	6,070.00 - 6,230.00
52-Week Range	3,415.00 - 24,400.00
Beta	n/a
Analysts	n/a
Price Target	n/a
Earnings Date	n/a

About DT&CRO CO.

DT&CRO CO., Ltd. operates as a full-service CRO provider in South Korea. It conducts a series of consigned studies ranging from non-clinical GLP toxicity, PK, and efficacy tests required for licensing of pharmaceuticals, chemicals, health functional foods, cosmetics, and medical devices to analysis, bioactivity, clinical trials, and licensing consulting. DT&CRO CO., Ltd. was founded in 2017 and is based in Yongin, South Korea.

• Industry: Commercial Physical and Biological Research
• Founded: 2017
• Country: South Korea
• Stock Exchange: KOSDAQ
• Ticker Symbol: 383930